Reading...
Play button
Play button
Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
256 Cards in this Set
- Front
- Back
|
5-ASA
|
5-aminosalicylic acid (medication)
|
|
|
5-FU
|
fluorouracil (medication)
|
|
|
ABG
|
arterial blood gases
|
|
|
ACE/ACEI
|
angiotensin-converting enzyme / angiotensin-converting enzyme inhibitor (class of medications)
|
|
|
AD
|
alzheimer’s disease
|
|
|
ADH
|
antidiuretic hormone
|
|
|
ADHD
|
attention deficit hyperactivity disorder
|
|
|
ADR
|
adverse drug reaction
|
|
|
AE; A/E
|
adverse effect / air entry
|
|
|
AF; AFib
|
atrial fibrillation
|
|
|
AIDS
|
acquired immune deficiency syndrome
|
|
|
ALP
|
alkaline phosphatase
|
|
|
ALT
|
alanine transaminase
|
|
|
aPTT
|
activated partial thromboplastin time
|
|
|
ARB
|
angiotensin receptor blocker (class of medications)
|
|
|
ASA
|
acetylsalicylic acid (medication)
|
|
|
AST
|
aspartate transaminase
|
|
|
AV
|
atrioventricular
|
|
|
AZA
|
azathioprine (medication)
|
|
|
AZT
|
zidovudine (medication)
|
|
|
BCP
|
birth control pills (class of medications)
|
|
|
BDZ
|
benzodiazepine (class of medications)
|
|
|
BG
|
blood glucose
|
|
|
BM
|
bowel movement
|
|
|
BMD
|
bone mineral density
|
|
|
BMI
|
body mass index
|
|
|
BMR
|
basal metabolic rate
|
|
|
BP
|
blood pressure; benzoyl peroxide (medication)
|
|
|
BPH
|
benign prostatic hyperplasia / hypertrophy
|
|
|
BPM
|
beats per minute
|
|
|
BSA
|
body surface area
|
|
|
BS
|
blood sugar; breath sounds; bowel sounds
|
|
|
BUN
|
blood urea nitrogen
|
|
|
C&S
|
culture and sensitivity
|
|
|
CA/Ca
|
cancer (calcium as well if + is forgotten)
|
|
|
CABG
|
coronary artery bypass graft
|
|
|
CAD
|
coronary artery disease
|
|
|
cal
|
calorie
|
|
|
CAP
|
community acquired pneumonia
|
|
|
CBC
|
complete blood count
|
|
|
CBZ
|
carbamazepine (medication)
|
|
|
CC
|
chief complaint; with meals; cubic centimetre
|
|
|
CCB
|
calcium channel blocker (class of medications)
|
|
|
CHD
|
coronary heart disease
|
|
|
CHF
|
congestive heart failure
|
|
|
CHO
|
carbohydrate
|
|
|
CI
|
contraindication
|
|
|
CK
|
creatinine kinase
|
|
|
ClCr/CrCl
|
creatinine clearance
|
|
|
CNS
|
central nervous system
|
|
|
COPD
|
chronic obstructive pulmonary disease
|
|
|
COXIB
|
cyclooxygenase-2-inhibitor (class of medications)
|
|
|
CP
|
chest pain
|
|
|
CPK
|
creatine phosphokinase
|
|
|
CPS
|
Compendium of Pharmaceuticals and Specialties
|
|
|
CPZ
|
chlorpromazine (medication)
|
|
|
CRP
|
c-reactive protein
|
|
|
CSF
|
cerebrospinal fluid
|
|
|
CVA
|
cerebrovascular accident
|
|
|
CVD
|
cardiovascular disease
|
|
|
DDAVP®
|
desmopressin acetate (medication)
|
|
|
DEET
|
diethyltoluamide (insect repellant)
|
|
|
DEXA
|
dual-energy x-ray absorptiometry
|
|
|
DI
|
drug interaction; drug information
|
|
|
Dig
|
digoxin (medication)
|
|
|
DIN
|
drug identification number; drug-induced nausea
|
|
|
DKA
|
diabetic ketoacidosis
|
|
|
DM
|
Diabetes Mellitis; dextromethorphan
|
|
|
DMARD
|
disease-modifying antirheumatic drugs (class of medications)
|
|
|
DOB
|
date of birth
|
|
|
DSM-IV
|
Diagnostic and Statistical Manual of Mental Disorders, 4th ed.
|
|
|
DU
|
duodenal ulcer
|
|
|
DVT
|
deep vein thrombosis
|
|
|
Dx
|
diagnosis
|
|
|
EC
|
emergency contraception; enteric coated
|
|
|
ECF
|
extracellular fluid
|
|
|
ECG
|
electrocardiogram
|
|
|
ECT
|
electroconvulsive therapy
|
|
|
ED
|
erectile dysfunction
|
|
|
EEG
|
electroencephalogram
|
|
|
EES®
|
erythromycin ethylsuccinate (medication)
|
|
|
EENT
|
eye, ear, nose, and throat
|
|
|
ENT
|
ear, nose, and throat
|
|
|
EPI
|
epinephrine (medication)
|
|
|
EPS
|
extrapyramidal side effect
|
|
|
ESR
|
erythrocyte sedimentation rate
|
|
|
ESRD
|
end stage renal disease
|
|
|
ETOH
|
ethyl alcohol
|
|
|
FAS
|
fetal alcohol syndrome
|
|
|
FBG
|
fasting blood glucose
|
|
|
FBS
|
fasting blood sugar
|
|
|
FEV
|
forced expiratory volume
|
|
|
FP
|
fluticasone propionate (medication)
|
|
|
FSH
|
follicle-stimulating hormone
|
|
|
fT3
|
free triiodothyronine
|
|
|
fT4
|
free thyroxine
|
|
|
FVC
|
forced vital capacity
|
|
|
GAD
|
generalized anxiety disorder
|
|
|
GERD
|
gastroesophageal reflux disease
|
|
|
GFR
|
glomerular filtration rate
|
|
|
GI
|
gastrointestinal
|
|
|
GT or G-tube
|
gastrostomy tube
|
|
|
GTN
|
nitroglycerin (medication)
|
|
|
GTT
|
glucose tolerance test
|
|
|
GU
|
genitourinary, gastric ulcer
|
|
|
H/A
|
headache
|
|
|
HAV
|
hepatitis A virus
|
|
|
HBV
|
hepatitis B virus
|
|
|
HC/HCT
|
hydrocortisone (medication)
|
|
|
HCT/HCTZ
|
hydrochlorothiazide (medication)
|
|
|
HCV
|
hepatitis C virus
|
|
|
HDL-C
|
high density lipoprotein cholesterol
|
|
|
HDV
|
hepatitis D (delta) virus
|
|
|
HEENT
|
head, eyes, ears, nose, and throat
|
|
|
HEPA
|
high efficiency particulate air
|
|
|
HFA
|
hydrofluoroalkane
|
|
|
Hflu
|
Haemophilis influenza
|
|
|
Hgb/Hb
|
hemoglobin
|
|
|
HIV
|
human immunodeficiency virus
|
|
|
HMG-CoA inh
|
hepatic hydroxymethylglutaryl coenzyme A inhibitors (class of medications)
|
|
|
HPV
|
human papilloma virus
|
|
|
HR
|
heart rate
|
|
|
H2RA
|
H2-receptor antagonist (class of medications)
|
|
|
HRT
|
hormone replacement therapy
|
|
|
HSV
|
herpes simplex virus
|
|
|
HTN
|
hypertension
|
|
|
Hx
|
history
|
|
|
HZ
|
herpes zoster
|
|
|
IA
|
intra-articular
|
|
|
IBD
|
inflammatory bowel disease
|
|
|
IBS
|
irritable bowel syndrome
|
|
|
IBW
|
ideal body weight
|
|
|
ICS
|
inhaled corticosteroids (class of medications)
|
|
|
ICU
|
intensive care unit
|
|
|
IDDM
|
insulin dependent diabetes mellitus
|
|
|
IDL
|
intermediate-density lipoproteins
|
|
|
IFG
|
impaired fasting glucose
|
|
|
IHD
|
ischemic heart disease
|
|
|
INH
|
isoniazid (medication)
|
|
|
INR
|
International Normalized Ratio
|
|
|
IOP
|
intraocular pressure
|
|
|
ISDN
|
isosorbide dinitrate (medication)
|
|
|
IU
|
international unit
|
|
|
IUD
|
intrauterine device
|
|
|
J-tube
|
jejunostomy tube
|
|
|
kcal
|
kilocalorie
|
|
|
LABA
|
long-acting beta2-agonist (class of medications)
|
|
|
LCD
|
coal tar solution
|
|
|
LDH
|
lactic dehydrogenase
|
|
|
LDL-C
|
low-density lipoprotein cholesterol
|
|
|
LFT
|
liver function test
|
|
|
LH
|
luteinizing hormone
|
|
|
Li
|
lithium (medication)
|
|
|
LMWH
|
low molecular weight heparin
|
|
|
LRTI
|
lower respiratory tract infection
|
|
|
LTRA
|
leukotriene receptor antagonist (class of medications)
|
|
|
LVH
|
left ventricular hypertrophy
|
|
|
LVPB
|
large volume piggyback
|
|
|
lytes
|
electrolytes
|
|
|
MAOI
|
monoamine oxidase inhibitor
|
|
|
MAR
|
medication administration record
|
|
|
MDI
|
metered-dose inhaler
|
|
|
MgSO4
|
magnesium sulphate / Epsom salts (see MSO4 below for potential error)
|
|
|
MI
|
myocardial infarction
|
|
|
MMSE
|
mini-mental mental state examination
|
|
|
MOM
|
milk of magnesium (medication)
|
|
|
MRSA
|
methicillin-resistant S. aureus
|
|
|
MS
|
motion sickness; multiple sclerosis; Morphine Sulphate
|
|
|
MSO4
|
morphine sulphate (please see MS & MgSO4 above - potential error)
|
|
|
MTX
|
methotrexate (medication)
|
|
|
N/A
|
no information available; not applicable
|
|
|
NE
|
norepinephrine
|
|
|
NG (-tube)
|
nasogastric (-tube)
|
|
|
NIDDM
|
non-insulin dependent diabetes mellitus
|
|
|
NMS
|
neuroleptic malignant syndrome
|
|
|
NPH
|
isophane insulin (medication)
|
|
|
NPO
|
nothing by mouth
|
|
|
NRT
|
nicotine replacement therapy
|
|
|
NS
|
normal saline
|
|
|
NSAID
|
nonsteroidal anti-inflammatory drug (class of medications)
|
|
|
NTG,nitro
|
nitroglycerin (medication)
|
|
|
N/V,N&V
|
nausea and vomiting
|
|
|
O2
|
oxygen
|
|
|
OA
|
osteoarthritis
|
|
|
OB
|
obstetrics
|
|
|
OC/OCP
|
oral contraceptive / oral contraceptive pills (class of medications)
|
|
|
OCD
|
obsessive compulsive disorder
|
|
|
Opth
|
ophthalmic/opthamology
|
|
|
OTC
|
over-the-counter (class of medications)
|
|
|
PCA
|
patient-controlled analgesia
|
|
|
PD
|
panic disorder
|
|
|
PE
|
physical examination, pulmonary embolism, premature ejaculation
|
|
|
PEF
|
peak expiratory flow
|
|
|
PEFR
|
peak expiratory flow rate
|
|
|
PFT
|
pulmonary function test
|
|
|
PG (inhibitors)
|
prostaglandin (synthetase inhibitors) (class of medications)
|
|
|
PKU
|
phenylketonuria
|
|
|
PMS
|
premenstrual syndrome
|
|
|
PP
|
postprandial
|
|
|
PPI
|
proton pump inhibitor
|
|
|
PSA
|
prostate specific antigen
|
|
|
PT
|
prothrombin time; patient (Pt. as well); physical therapy
|
|
|
PTT
|
partial thromboplastin time
|
|
|
PTU
|
propylthiouracil (medication)
|
|
|
PUD
|
peptic ulcer disease
|
|
|
PVC
|
premature ventricular contraction
|
|
|
PVD
|
peripheral vascular disease
|
|
|
RA
|
rheumatoid arthritis
|
|
|
RBC
|
red blood cell
|
|
|
RDA
|
recommended daily allowance
|
|
|
REM
|
rapid eye movement
|
|
|
RNI
|
recommended nutrient intake
|
|
|
RVH
|
right ventricular hypertrophy
|
|
|
Rx
|
prescription
|
|
|
SABA
|
short-acting beta2-agonist (class of medications)
|
|
|
SAD
|
seasonal affective disorder
|
|
|
SCr,SeCr
|
serum creatinine
|
|
|
SERM
|
selective estrogen receptor modulator (class of medications)
|
|
|
SIADH
|
syndrome of inappropriate antidiuretic hormone
|
|
|
SJS
|
Stevens-Johnson syndrome
|
|
|
SLE
|
systemic lupus erythrematosus
|
|
|
SNRI
|
serotonin and norepinephrine reuptake inhibitor (class of medications)
|
|
|
SOAP
|
subjective, objective, assessment, and plans
|
|
|
SOB
|
shortness of breath
|
|
|
SPF
|
sun protective factor
|
|
|
SSRI
|
selective
|
|
|
STD
|
sexually
|
|
|
Sx
|
symptom
|
|
|
TC
|
total
|
|
|
TCA
|
tricyclic
|
|
|
TG
|
triglycerides
|
|
|
TIA
|
transient
|
|
|
TMP/SMX
|
trimethoprim/sulfamethoxazole
|
|
|
TPN
|
total
|
|
|
TSH
|
thyroid
|
|
|
TSS
|
toxic
|
|
|
Tx/TX
|
treatment
|
|
|
TZD
|
thiazolidinediones
|
|
|
UA;
|
U/A
|
|
|
UC
|
ulcerative
|
|
|
UGI
|
upper
|
|
|
URTI
|
upper
|
|
|
UTI
|
urinary
|
|
|
UVA
|
ultraviolet-A
|
|
|
UVB
|
ultraviolet-B
|
|
|
UVC
|
ultraviolet-C
|
|
|
VF;
|
V
|
|
|
VLDL
|
very
|
|
|
VO
|
verbal
|
|
|
VS
|
vital
|
|
|
VT
|
ventricular
|
|
|
WBC
|
white
|
|
|
WC
|
waist
|
|
|
WNL
|
within
|
|
|
W/O
|
without
|
|
|
Wt
|
weight
|
